Home › Funds › 72 Investment Holdings, LLC › ANRO
72 Investment Holdings, LLC position in ANRO
ALTO NEUROSCIENCE INC · Health Care
72 Investment Holdings, LLC reported holding 667,778 shares of ANRO (ALTO NEUROSCIENCE INC) in its Q3 2026 13F filing — a position valued at US$17.0M, representing 31.02% of its reported portfolio and ranking #2 among its reported holdings. 72 Investment Holdings, LLC has disclosed ANRO holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How 72 Investment Holdings, LLC's ANRO position evolved
72 Investment Holdings, LLC first disclosed a stake in ANRO in Q1 2024 at 667,778 shares (US$10.3M). The position peaked in Q2 2026 at 667,778 shares, worth US$17.6M. Across 11 filings, 72 Investment Holdings, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 667,778 shares valued at US$17.0M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 667.78K | $10.25M | New |
| Q2 2024 | 667.78K | $7.14M | Hold |
| Q3 2024 | 667.78K | $7.64M | Hold |
| Q4 2024 | 667.78K | $2.82M | Hold |
| Q1 2025 | 667.78K | $1.44M | Hold |
| Q2 2025 | 667.78K | $1.47M | Hold |
| Q3 2025 | 667.78K | $2.68M | Hold |
| Q4 2025 | 667.78K | $11.89M | Hold |
| Q1 2026 | 667.78K | $15.01M | Hold |
| Q2 2026 | 667.78K | $17.62M | Hold |
| Q3 2026 | 667.78K | $17.05M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ANRO and 13F data
ANRO (ALTO NEUROSCIENCE INC) is a Health Care company. 60 other funds we track also report a position in ANRO — the largest reported positions include Alpha Wave Global, LP (US$94.7M), Commodore Capital LP (US$69.5M), EcoR1 Capital, LLC (US$57.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ANRO
- Alpha Wave Global, LP 3.71M sh · $94.66M · Q3 2026
- Commodore Capital LP 2.72M sh · $69.52M · Q3 2026
- EcoR1 Capital, LLC 2.23M sh · $56.98M · Q3 2026
- PERCEPTIVE ADVISORS LLC 1.76M sh · $44.96M · Q3 2026
- Spruce Street Capital LP 1.68M sh · $42.80M · Q3 2026
- Vivo Capital, LLC 1.36M sh · $34.72M · Q3 2026
- Bellevue Group AG 1.16M sh · $29.71M · Q3 2026
- Parkman Healthcare Partners LLC 948.86K sh · $24.22M · Q3 2026
- Affinity Asset Advisors, LLC 643.34K sh · $16.42M · Q3 2026
- Saturn V Capital Management LP 518.11K sh · $13.23M · Q3 2026
- Integral Health Asset Management, LLC 500.00K sh · $12.77M · Q3 2026
- Venrock Adviser, LLC 500.00K sh · $12.77M · Q3 2026
More on 72 Investment Holdings, LLC
FAQ
How long has 72 Investment Holdings, LLC held ANRO?
72 Investment Holdings, LLC has disclosed ANRO holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
What is 72 Investment Holdings, LLC's current position in ANRO?
As of Q3 2026, 72 Investment Holdings, LLC holds 667.78K shares of ANRO (ALTO NEUROSCIENCE INC), valued at $17.05M, representing 31.02% of its reported portfolio and ranking #2.
Has 72 Investment Holdings, LLC been buying or selling ANRO?
In the latest 13F filing (Q3 2026), 72 Investment Holdings, LLC held unchanged its position in ANRO. The position peaked in Q2 2026 at 667.78K shares.
Which other funds hold ANRO?
Other major institutional holders of ANRO include Alpha Wave Global, LP, Commodore Capital LP, EcoR1 Capital, LLC, among 60 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.